Covid-19 Live Updates: Pfizer Seeks Full F.D.A. Approval for Its Vaccine

Here’s what you need to know: Ton Tran, 106, receiving his second dose of the Pfizer-BioNTech Covid-19 vaccine at a clinic in San Jose, Calif., on Thursday.Credit…Noah Berger/Associated Press Pfizer and the German company BioNTech have become the first companies to apply to the U.S. Food and Drug Administration for full approval of their Covid-19 vaccine…

Published
Categorized as News

Pfizer Reaps Hundreds of Millions in Profits From Covid Vaccine

The pricing for the United States was in line with the cost of seasonal flu vaccines and much less expensive than vaccines for conditions like shingles, which can run into several hundred dollars. “That price point does not seem offensive, even if you don’t spend a lot of time thinking about prescription drugs,” said Stacie…

Published
Categorized as News

Covid-19 Live Updates: Pfizer Vaccine Is Set to Be Approved for Adolescents in U.S.

Here’s what you need to know: Keidy Ventura, 17, received a dose of the Pfizer coronavirus vaccine in West New York, N.J., last month.Credit…Seth Wenig/Associated Press Medical experts welcomed the news that the Pfizer-BioNTech Covid vaccine could be authorized by the Food and Drug Administration for use in adolescents ages 12 to 15 by early…

Published
Categorized as News

F.D.A. Set to Authorize Pfizer Vaccine for Adolescents by Early Next Week

WASHINGTON — The Food and Drug Administration is preparing to authorize use of the Pfizer-BioNTech coronavirus vaccine in adolescents 12 to 15 years old by early next week, according to federal officials familiar with the agency’s plans, opening up the U.S. vaccination campaign to millions more people. Some parents have been counting down the weeks…

Published
Categorized as News

How Europe Sealed a Pfizer Vaccine Deal With Texts and Calls

BRUSSELS — It was February and things were going from bad to worse for the European Union’s vaccination campaign, and for its top executive, Ursula von der Leyen. Much of Europe was in lockdown, people were dying and the bloc was running low on doses of vaccines after its biggest supplier, AstraZeneca, announced production problems.…

Published
Categorized as News